Cargando…
The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
OBJECTIVE: To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). DESIGN: Cohort study using medical databases. SETTING: Northern Denmark. PARTICIPANTS: On 1 January 2005, we identified all patients w...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275660/ https://www.ncbi.nlm.nih.gov/pubmed/25526796 http://dx.doi.org/10.1136/bmjopen-2014-006720 |
_version_ | 1782350162445729792 |
---|---|
author | Schmidt, Sigrun Alba Johannesdottir Johansen, Martin Berg Olsen, Morten Xu, Xiao Parker, Joseph M Molfino, Nestor A Lash, Timothy L Sørensen, Henrik Toft Christiansen, Christian Fynbo |
author_facet | Schmidt, Sigrun Alba Johannesdottir Johansen, Martin Berg Olsen, Morten Xu, Xiao Parker, Joseph M Molfino, Nestor A Lash, Timothy L Sørensen, Henrik Toft Christiansen, Christian Fynbo |
author_sort | Schmidt, Sigrun Alba Johannesdottir |
collection | PubMed |
description | OBJECTIVE: To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). DESIGN: Cohort study using medical databases. SETTING: Northern Denmark. PARTICIPANTS: On 1 January 2005, we identified all patients with prevalent hospital-diagnosed chronic obstructive pulmonary disease (COPD) who had at least one AECOPD during 1 January 2005 to 31 December 2009. We followed patients from the first AECOPD during this period until death, emigration or 31 December 2009, whichever came first. We flagged all AECOPD events during follow-up and characterised each by the exacerbation frequency (0, 1, 2 or 3+) in the prior 12-month period. MAIN OUTCOMES AND MEASURES: Using Cox regression, we computed 0–30-day and 31–365-day age-adjusted, sex-adjusted, and comorbidity-adjusted mortality rate ratios (MRRs) with 95% CIs entering exacerbation frequency as a time-varying exposure. RESULTS: We identified 16 647 eligible patients with prevalent COPD, of whom 6664 (40%) developed an AECOPD and were thus included in the study cohort. The 0–30-day MRRs were 0.97 (95% CI 0.80 to 1.18), 0.90 (95% CI 0.70 to 1.15) and 1.03 (95% CI 0.81 to 1.32) among patients with AECOPD with 1, 2 and 3+ AECOPDs versus no AECOPD within the past 12 months, respectively. The corresponding MRRs were 1.47 (95% CI 1.30 to 1.66), 1.89 (95% CI 1.59 to 2.25) and 1.59 (95% CI 1.23 to 2.05) for days 31–365. CONCLUSION: Among patients with AECOPD, one or more exacerbations in the previous year were not associated with 30-day mortality but were associated with an increased 31–365-day mortality. |
format | Online Article Text |
id | pubmed-4275660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-42756602014-12-31 The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study Schmidt, Sigrun Alba Johannesdottir Johansen, Martin Berg Olsen, Morten Xu, Xiao Parker, Joseph M Molfino, Nestor A Lash, Timothy L Sørensen, Henrik Toft Christiansen, Christian Fynbo BMJ Open Respiratory Medicine OBJECTIVE: To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). DESIGN: Cohort study using medical databases. SETTING: Northern Denmark. PARTICIPANTS: On 1 January 2005, we identified all patients with prevalent hospital-diagnosed chronic obstructive pulmonary disease (COPD) who had at least one AECOPD during 1 January 2005 to 31 December 2009. We followed patients from the first AECOPD during this period until death, emigration or 31 December 2009, whichever came first. We flagged all AECOPD events during follow-up and characterised each by the exacerbation frequency (0, 1, 2 or 3+) in the prior 12-month period. MAIN OUTCOMES AND MEASURES: Using Cox regression, we computed 0–30-day and 31–365-day age-adjusted, sex-adjusted, and comorbidity-adjusted mortality rate ratios (MRRs) with 95% CIs entering exacerbation frequency as a time-varying exposure. RESULTS: We identified 16 647 eligible patients with prevalent COPD, of whom 6664 (40%) developed an AECOPD and were thus included in the study cohort. The 0–30-day MRRs were 0.97 (95% CI 0.80 to 1.18), 0.90 (95% CI 0.70 to 1.15) and 1.03 (95% CI 0.81 to 1.32) among patients with AECOPD with 1, 2 and 3+ AECOPDs versus no AECOPD within the past 12 months, respectively. The corresponding MRRs were 1.47 (95% CI 1.30 to 1.66), 1.89 (95% CI 1.59 to 2.25) and 1.59 (95% CI 1.23 to 2.05) for days 31–365. CONCLUSION: Among patients with AECOPD, one or more exacerbations in the previous year were not associated with 30-day mortality but were associated with an increased 31–365-day mortality. BMJ Publishing Group 2014-12-19 /pmc/articles/PMC4275660/ /pubmed/25526796 http://dx.doi.org/10.1136/bmjopen-2014-006720 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Respiratory Medicine Schmidt, Sigrun Alba Johannesdottir Johansen, Martin Berg Olsen, Morten Xu, Xiao Parker, Joseph M Molfino, Nestor A Lash, Timothy L Sørensen, Henrik Toft Christiansen, Christian Fynbo The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study |
title | The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study |
title_full | The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study |
title_fullStr | The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study |
title_full_unstemmed | The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study |
title_short | The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study |
title_sort | impact of exacerbation frequency on mortality following acute exacerbations of copd: a registry-based cohort study |
topic | Respiratory Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275660/ https://www.ncbi.nlm.nih.gov/pubmed/25526796 http://dx.doi.org/10.1136/bmjopen-2014-006720 |
work_keys_str_mv | AT schmidtsigrunalbajohannesdottir theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT johansenmartinberg theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT olsenmorten theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT xuxiao theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT parkerjosephm theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT molfinonestora theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT lashtimothyl theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT sørensenhenriktoft theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT christiansenchristianfynbo theimpactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT schmidtsigrunalbajohannesdottir impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT johansenmartinberg impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT olsenmorten impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT xuxiao impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT parkerjosephm impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT molfinonestora impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT lashtimothyl impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT sørensenhenriktoft impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy AT christiansenchristianfynbo impactofexacerbationfrequencyonmortalityfollowingacuteexacerbationsofcopdaregistrybasedcohortstudy |